BHV-1300

Asset

Bispecific extracellular pan-IgG degrader targeting IgG to asialoglycoprotein receptors

Stage
Phase 3
Modality
Protein or enzyme
Target
Inflammation
1
Indication
0
Trials
1
Developer

Indications

1

In the full profile

  • Targets and what it contains2
  • Owner and partners2
  • Evidence for its targets2
  • Aging relevance1
  • Signals1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets